{"entity":{"id":"nct05584800","kind":"trial","name":"Study of ZGGS18 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of ZGGS18 for Injection in advanced solid tumours, run by Suzhou Zelgen Biopharmaceuticals Co.,Ltd, now recruiting.","summary":"Study of ZGGS18 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT05584800 by Suzhou Zelgen Biopharmaceuticals Co.,Ltd, with 222 participants planned, started 2022-11-15 and due to reach its primary completion in 2026-11-01. Interventions recorded: ZGGS18 for Injection.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05584800","url":"https://clinicaltrials.gov/study/NCT05584800"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["zelgen"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05584800","phase":"1/2","setting":"A Phase I/II Dose Escalation, Tolerability, Safety, Pharmacokinetics and Multiple Cohort Expansion Study of ZGGS18 in Patients With Advanced Solid Tumors","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","participation":[{"nct":"NCT05584800","source":"https://clinicaltrials.gov/study/NCT05584800","fetchedAt":"2026-10-07T16:53:46.156Z","studySha256":"7508cf2c71bdc6590a704e12a0cb4cf7eb656870099cf569b06e9609d489dd81","overallStatus":"RECRUITING","lastUpdatePosted":"2026-01-05","leadSponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":222,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2022-11-15","startedType":"actual","enrolled":222,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05584800/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"zelgen","kind":"company","name":"Suzhou Zelgen Biopharmaceuticals","route":"/companies/zelgen/"}]}}